Literature DB >> 26495760

Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.

Yasushi Mabuchi1, Tamaki Yahata, Aya Kobayashi, Yuko Tanizaki, Michihisa Shiro, Nami Ota, Shigetaka Yagi, Sawako Minami, Kazuhiko Ino.   

Abstract

OBJECTIVE: The aim of this study was to clarify the clinicopathologic factors of stages IB to IIB cervical adenocarcinoma.
METHODS: Several clinicopathologic factors were compared between 35 patients who underwent radical hysterectomy and pelvic lymphadenectomy due to cervical adenocarcinoma stages IB to IIB and 77 patients with squamous cell carcinoma (SCC).
RESULTS: In patients with adenocarcinoma, univariate analysis demonstrated that International Federation of Gynecology and Obstetrics stage, tumor size, and lymphovascular space invasion were significantly associated with progression-free survival (PFS), whereas FIGO stage, lymphovascular space invasion, and lymph node metastasis were significantly associated with overall survival (OS). However, multivariate analysis revealed that FIGO stage was the only significant factor for PFS in patients with adenocarcinoma. In patients with SCC, univariate analysis demonstrated that FIGO stage and lymph node metastasis were significantly associated with PFS, whereas FIGO stage, lymphovascular space invasion, and lymph node metastasis were significantly associated with OS. Multivariate analysis revealed that lymph node metastasis was the only significant factor for PFS and OS in patients with SCC. In 26 patients who were positive for high-risk human papillomavirus (HPV), including both adenocarcinoma and SCC patients, univariate and multivariate analyses revealed that HPV18 was significantly associated with poorer PFS compared with non-HPV18. There was a significant difference in distribution of HPV genotype between adenocarcinoma and SCC.
CONCLUSIONS: Careful treatment may be necessary for the patients with lymphovascular space invasion in early-stage cervical adenocarcinoma. The presence of HPV18 may have an influence on the prognosis of early-stage cervical carcinoma.

Entities:  

Mesh:

Year:  2015        PMID: 26495760     DOI: 10.1097/IGC.0000000000000542

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Primary tumor SUVmax on preoperative FDG-PET/CT is a prognostic indicator in stage IA2-IIB cervical cancer patients treated with radical hysterectomy.

Authors:  Shigetaka Yagi; Tamaki Yahata; Yasushi Mabuchi; Yuko Tanizaki; Aya Kobayashi; Michihisa Shiro; Nami Ota; Sawako Minami; Masaki Terada; Kazuhiko Ino
Journal:  Mol Clin Oncol       Date:  2016-07-07

2.  Micropapillary Cervical Adenocarcinoma: A Clinicopathologic Study of 44 Cases.

Authors:  Isabel Alvarado-Cabrero; W Glenn McCluggage; Rafael Estevez-Castro; Delia Pérez-Montiel; Simona Stolnicu; Raji Ganesan; Josefa Vella; Rosario Castro; Javier Canedo-Matute; Jessica Gomez-Cifuentes; Vilma M Rivas-Lemus; Kay J Park; Robert A Soslow; Esther Oliva; Raquel Valencia-Cedillo
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

3.  Is there different prognosis between cervical endometrioid adenocarcinoma and ordinary cervical adenocarcinoma in a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database?

Authors:  Fubin Zhang; Bohong Jin; Hui Yan; Tianhong Zhu; Huiqing Ding; Xueqin Chen; Yutao Guan
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

4.  Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis.

Authors:  Yunhua Yi; Jiangxin Sheng; Jichan Nie
Journal:  Ann Transl Med       Date:  2022-05

5.  Combined Evaluation of Preoperative Serum CEA and CA125 as an Independent Prognostic Biomarker in Patients with Early-Stage Cervical Adenocarcinoma.

Authors:  Genping Huang; Ruizhe Chen; Nanjia Lu; Qin Chen; Weiguo Lv; Baohua Li
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

6.  Clinicopathological characteristics and prognostic factors of cervical adenocarcinoma.

Authors:  Min Wang; Bo Yuan; Zhen-Huan Zhou; Wei-Wei Han
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.379

7.  Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study.

Authors:  San Gang Wu; Jia Yuan Sun; Zhen Yu He; Qiong Hua Chen; Juan Zhou
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.